Schizophrenia
|
0.370 |
GeneticVariation
|
disease |
LHGDN |
Variations in the VMAT1 gene might affect transporter function and/or expression, and might be involved in the etiology of SZ.
|
18451639 |
2008 |
Schizophrenia
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Variations in the VMAT1 gene might affect transporter function and/or expression and might be involved in the etiology of BPD and/or SZ.
|
16936705 |
2006 |
Schizophrenia
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
The gene encoding the vesicular monoamine transporter 1 (VMAT1/SLC18A1) maps to chromosome 8p21, a region where several linkage peaks overlap between schizophrenia, bipolar disorder and anxiety-related personality traits.
|
18249496 |
2008 |
Schizophrenia
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Variations in the VMAT1 gene might affect transporter function and/or expression, and might be involved in the etiology of SZ.
|
18451639 |
2008 |
Schizophrenia
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, several recent genetic case-control studies have documented an association between common missense variations in the VMAT1 gene and susceptibility to bipolar disorder and schizophrenia.
|
20419435 |
2010 |
Mental Depression
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Molecular genetics and developmental studies have identified 21 genes in this region (ADRA1A, ARHGEF10, CHRNA2, CHRNA6, CHRNB3, DKK4, DPYSL2, EGR3, FGF17, FGF20, FGFR1, FZD3, LDL, NAT2, NEF3, NRG1, PCM1, PLAT, PPP3CC, SFRP1 and VMAT1/SLC18A1) that are most likely to contribute to neuropsychiatric disorders (schizophrenia, autism, bipolar disorder and depression), neurodegenerative disorders (Parkinson's and Alzheimer's disease) and cancer.
|
19204725 |
2009 |
Mental Depression
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Our results may contribute to the evidence indicating an association between the VMAT1 gene and structural brain alterations in depression.
|
28408293 |
2017 |
Depressive disorder
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Our results may contribute to the evidence indicating an association between the VMAT1 gene and structural brain alterations in depression.
|
28408293 |
2017 |
Depressive disorder
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Molecular genetics and developmental studies have identified 21 genes in this region (ADRA1A, ARHGEF10, CHRNA2, CHRNA6, CHRNB3, DKK4, DPYSL2, EGR3, FGF17, FGF20, FGFR1, FZD3, LDL, NAT2, NEF3, NRG1, PCM1, PLAT, PPP3CC, SFRP1 and VMAT1/SLC18A1) that are most likely to contribute to neuropsychiatric disorders (schizophrenia, autism, bipolar disorder and depression), neurodegenerative disorders (Parkinson's and Alzheimer's disease) and cancer.
|
19204725 |
2009 |
Bipolar Disorder
|
0.310 |
GeneticVariation
|
disease |
LHGDN |
The vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) maps to the shared bipolar disorder (BPD)/schizophrenia (SZ) susceptibility locus on chromosome 8p21.
|
16936705 |
2006 |
Autistic Disorder
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Association study of the vesicular monoamine transporter 1 (VMAT1) gene with autism in an Iranian population.
|
28476685 |
2017 |
Autistic Disorder
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
The gene for solute carrier family 18 member A1 (vesicular monoamine transporter; SLC18A1) is of particular interest in this regard because of its association with schizophrenia, autism and bipolar illness as well as with cancer.
|
30194079 |
2018 |
Malignant Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Molecular genetics and developmental studies have identified 21 genes in this region (ADRA1A, ARHGEF10, CHRNA2, CHRNA6, CHRNB3, DKK4, DPYSL2, EGR3, FGF17, FGF20, FGFR1, FZD3, LDL, NAT2, NEF3, NRG1, PCM1, PLAT, PPP3CC, SFRP1 and VMAT1/SLC18A1) that are most likely to contribute to neuropsychiatric disorders (schizophrenia, autism, bipolar disorder and depression), neurodegenerative disorders (Parkinson's and Alzheimer's disease) and cancer.
|
19204725 |
2009 |
Depressed mood
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
Our results may contribute to the evidence indicating an association between the VMAT1 gene and structural brain alterations in depression.
|
28408293 |
2017 |
Depressed mood
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
Molecular genetics and developmental studies have identified 21 genes in this region (ADRA1A, ARHGEF10, CHRNA2, CHRNA6, CHRNB3, DKK4, DPYSL2, EGR3, FGF17, FGF20, FGFR1, FZD3, LDL, NAT2, NEF3, NRG1, PCM1, PLAT, PPP3CC, SFRP1 and VMAT1/SLC18A1) that are most likely to contribute to neuropsychiatric disorders (schizophrenia, autism, bipolar disorder and depression), neurodegenerative disorders (Parkinson's and Alzheimer's disease) and cancer.
|
19204725 |
2009 |
Primary malignant neoplasm
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Molecular genetics and developmental studies have identified 21 genes in this region (ADRA1A, ARHGEF10, CHRNA2, CHRNA6, CHRNB3, DKK4, DPYSL2, EGR3, FGF17, FGF20, FGFR1, FZD3, LDL, NAT2, NEF3, NRG1, PCM1, PLAT, PPP3CC, SFRP1 and VMAT1/SLC18A1) that are most likely to contribute to neuropsychiatric disorders (schizophrenia, autism, bipolar disorder and depression), neurodegenerative disorders (Parkinson's and Alzheimer's disease) and cancer.
|
19204725 |
2009 |
Alzheimer's Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Molecular genetics and developmental studies have identified 21 genes in this region (ADRA1A, ARHGEF10, CHRNA2, CHRNA6, CHRNB3, DKK4, DPYSL2, EGR3, FGF17, FGF20, FGFR1, FZD3, LDL, NAT2, NEF3, NRG1, PCM1, PLAT, PPP3CC, SFRP1 and VMAT1/SLC18A1) that are most likely to contribute to neuropsychiatric disorders (schizophrenia, autism, bipolar disorder and depression), neurodegenerative disorders (Parkinson's and Alzheimer's disease) and cancer.
|
19204725 |
2009 |
Anorexia Nervosa
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Following on from previous work by our group where we showed that early onset anorexia nervosa (AN) and obsessive-compulsive disorder (OCD) shared a common genetic background, the aim of the present study is to assess genetic pleiotropy related to the serotonergic system (SLC6A4, 5HTR2A, 5HTR2C, TPH2, SLC18A1), in a common phenotype such as very-early age of onset.
|
30554102 |
2019 |
Borderline Personality Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Results suggest that variations in the VMAT1 gene may confer susceptibility to BPD in patients of European descent.
|
16936705 |
2006 |
Bronchopulmonary Dysplasia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Results suggest that variations in the VMAT1 gene may confer susceptibility to BPD in patients of European descent.
|
16936705 |
2006 |
Colorectal Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In summary, the germline deletions at SLC18A1 contributed to the development of CRC.
|
28968818 |
2017 |
Obsessive-Compulsive Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Following on from previous work by our group where we showed that early onset anorexia nervosa (AN) and obsessive-compulsive disorder (OCD) shared a common genetic background, the aim of the present study is to assess genetic pleiotropy related to the serotonergic system (SLC6A4, 5HTR2A, 5HTR2C, TPH2, SLC18A1), in a common phenotype such as very-early age of onset.
|
30554102 |
2019 |
Alcohol withdrawal syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This study shows that genetic variants in VMAT1, including the functional SNP rs1390938, contribute to the severity of AW in patients of European descent.
|
26876819 |
2016 |
Neurodegenerative Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Molecular genetics and developmental studies have identified 21 genes in this region (ADRA1A, ARHGEF10, CHRNA2, CHRNA6, CHRNB3, DKK4, DPYSL2, EGR3, FGF17, FGF20, FGFR1, FZD3, LDL, NAT2, NEF3, NRG1, PCM1, PLAT, PPP3CC, SFRP1 and VMAT1/SLC18A1) that are most likely to contribute to neuropsychiatric disorders (schizophrenia, autism, bipolar disorder and depression), neurodegenerative disorders (Parkinson's and Alzheimer's disease) and cancer.
|
19204725 |
2009 |
Major Depressive Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Diffusion tensor imaging (DTI) and VMAT1 rs1390938" genes_norm="6570">Thr136Ile (rs1390938) genotyping were performed on 103 patients diagnosed with MDD and 83 healthy control participants.
|
28408293 |
2017 |